Not recruiting
Type 2 diabetes mellitus+2
Not recruitingStudy of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
Registered drug
Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
Registered drug
- Disease:Type 2 diabetes mellitusObesity+1
- Substances:NNC0519-0130Semaglutide
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:NNC0519-0130



